Clinically Validated
by Center for Veterinary Integrative Medicine, Seoul National University
Innovative Solutions for Intractable Pet Diseases
PETMUNIOME and KIDNIOME simultaneously target and improve the Tri-axes of Gut, Immune, and Kidney Health.
PETMUNIOME
PETMUNIOME is an immune-strengthening product that demonstrated an average 28.9% improvement across 11 key biomarkers in a 3-month clinical trial involving 4 dogs with terminal cancer.
| 11 Key Biomarkers | Average 28.9% improvement (Key markers : Lymphocyte 48.2%, CRP 21.3% improved)) |
| Immune Markers | 33.2% Improvement (WBC, Lymphocyte, CRP) |
| Kidney Markers | 31.2% Improvement (Creatinine, BUN, UPC, Albumin) |
| Metabolic Markers | 23.3% Improvement (Glucose, Protein, Amylase, Lipase) |
| Average Weight Gain/Maintenance | 2.8% Increase (6.45kg → 6.63kg) |
| Clinical Observation | Improved appetite and increased activity level |
* Source: Seoul National University Integrative Veterinary Medicine Center / 3-month clinical data
* Published in 'Applied Biological Chemistry' (Oct 2023)
KIDNIOME
KIDNIOME is a kidney function recovery support product that demonstrated an average 19.9% improvement across 11 key biomarkers in a 3-month clinical trial involving 4 cats with end-stage kidney failure.
| 11 Key Biomarkers | Average 19.9% improvement (Key markers : Ammonia 46.3%, Creatinine 27.6% improved) |
| Immune Markers | 4.0% Improvement (WBC, Lymphocyte) |
| Kidney Markers | 26.9% Improvement (Creatinine, BUN, UPC, Albumin, Ammonia) |
| Metabolic Markers | 14.2% Improvement (Glucose, Protein, Amylase, Lipase) |
| Average Weight Loss/Maintenance | -1.7% Decrease (5.27kg → 5.18kg) |
| Clinical Observation | Improved appetite and increased activity level |
* Source: Seoul National University Integrative Veterinary Medicine Center / 3-month clinical data
* Published in 'Veterinary Integrative Science' (July 2023)
Clinically Validated
by Center for Veterinary Integrative Medicine, Seoul National University
Innovative Solutions for Intractable Pet Diseases
PETMUNIOME and KIDNIOME simultaneously target and improve the Tri-axes of Gut, Immune, and Kidney Health.
Natural Composition
Mechanism of action based on SCI-level papers of key ingredients
Key Ingredients(Natural Herb-Based)
Dendropanax morbifera, Portulaca oleracea, Saururus chinensis, Rehmannia glutinosa, Cornus officinalis, Poria cocos, Probiotics, and more
Pipeline Development
* 10 Natural Herb-Based Therapeutics Completed
· Various viral diseases, heart disease, chronic infections, arthritis, lung disease, diabetes, constipation, obesity, etc.
* 2 Microbiome Therapeutics currently in development
PETMUNIOME
PETMUNIOME is an immune-strengthening product that demonstrated an average 28.9% improvement across 11 key biomarkers in a 3-month clinical trial involving 4 dogs with terminal cancer.
| 11 Key Biomarkers | Average 28.9% improvement (Key markers : Lymphocyte 48.2%, CRP 21.3% improved)) |
| Immune Markers | 33.2% Improvement (WBC, Lymphocyte, CRP) |
| Kidney Markers | 31.2% Improvement (Creatinine, BUN, UPC, Albumin) |
| Metabolic Markers | 23.3% Improvement (Glucose, Protein, Amylase, Lipase) |
| Average Weight Gain/Maintenance | 2.8% Increase (6.45kg → 6.63kg) |
| Clinical Observation | Improved appetite and increased activity level |
* Source: Seoul National University Integrative Veterinary Medicine Center / 3-month clinical data
* Published in 'Applied Biological Chemistry' (Oct 2023)
KIDNIOME
KIDNIOME is a kidney function recovery support product that demonstrated an average 19.9% improvement across 11 key biomarkers in a 3-month clinical trial involving 4 cats with end-stage kidney failure.
| 11 Key Biomarkers | Average 19.9% improvement (Key markers : Ammonia 46.3%, Creatinine 27.6% improved) |
| Immune Markers | 4.0% Improvement (WBC, Lymphocyte) |
| Kidney Markers | 26.9% Improvement (Creatinine, BUN, UPC, Albumin, Ammonia) |
| Metabolic Markers | 14.2% Improvement (Glucose, Protein, Amylase, Lipase) |
| Average Weight Loss/Maintenance | -1.7% Decrease (5.27kg → 5.18kg) |
| Clinical Observation | Improved appetite and increased activity level |
* Source: Seoul National University Integrative Veterinary Medicine Center / 3-month clinical data
* Published in 'Veterinary Integrative Science' (July 2023)
Natural Composition
Mechanism of action based on SCI-level papers of key ingredients
Key Ingredients(Natural Herb-Based)
Dendropanax morbifera, Portulaca oleracea, Saururus chinensis, Rehmannia glutinosa, Cornus officinalis, Poria cocos, Probiotics, and more
Pipeline Development
* 10 Natural Herb-Based Therapeutics Completed
· Various viral diseases, heart disease, chronic infections, arthritis, lung disease, diabetes, constipation, obesity, etc.
* 2 Microbiome Therapeutics currently in development
Company Name | ANIBIOME Co., Ltd.
CEO | Chang Un-sang
Tel | 070-7776-0029
Email | cus1619@gmail.com
Business Registration No. |
222-88-03513
Address
A-625, Gwangmyeong G-Tower,
190, Soha-ro, Gwangmyeong-si,
Gyeonggi-do, Republic of Korea
Company Name | ANIBIOME Co., Ltd.
CEO | Chang Un-sang Tel | 070-7776-0029 Email | cus1619@gmail.com Business Registration No. | 222-88-03513
Address | A-625, Gwangmyeong G-Tower, 190, Soha-ro, Gwangmyeong-si, Gyeonggi-do, Republic of Korea
©2021. Anibiome Co., Ltd. All Rights Reserved.
